Abhi Basu

Founder, CommsRx and Signal Fidelity Group.

Abhi Basu has spent more than two decades helping global pharma and medtech companies launch and communicate, including in-house roles at Johnson & Johnson MedTech and Takeda. Much of that work was as the intermediary between brand and communications teams and their medical, legal and regulatory reviewers: the seat where strategy has to survive review.

He founded CommsRx to give communications leaders a system that holds that thread, from counsel to a confirmed strategy, messages, materials and review, with an AI agent, Ally, that proposes and a named person who decides. He also founded Signal Fidelity Group, which publishes research on how AI answer engines handle health information, including The Disclosure Effect (2026).

Abhi edits every article on CommsRx Insights.

Writing and research

• CommsRx Insights
• The Disclosure Effect, Signal Fidelity Group
• A letter from the founder
• Abhi Basu on LinkedIn

Contact

help@signalfidelitygroup.com